Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
KRAS has been one of the most hard-to-hit targets in cancer research.
In early experiments, researchers found that “the antibiotics [could] buy the precious time needed for immunotherapy to kick in.”
BO-112 helped make tumor cells more vulnerable to immunotherapy, offering a possible treatment route for hard-to-treat cancers.
A study in obese mice suggests weight loss could slow cancer growth.
“With BAX, we have a single target for blocking both types of cell death stemming from the use of doxorubicin."
This benefit was independent of weight control among the animals.
Australian researchers conducted experiments on mice that they fed only every other day.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
A set of mouse studies shows that this dietary intervention could be groundbreaking for breast cancer research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.